Welcome to our dedicated page for CACI INTERNATIONAL /DE/ SEC filings (Ticker: CACI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CACI INTERNATIONAL /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CACI INTERNATIONAL /DE/'s regulatory disclosures and financial reporting.
Director Charles L. Szews exercised 85 Restricted Stock Units into 85 shares of CACI common stock on July 13, 2026. These RSUs are part of a 338-unit grant dated October 16, 2025 with scheduled vesting through October 11, 2026. Following the transaction, Szews holds 584 CACI common shares and 85 RSUs directly.
Director Philip O. Nolan acquired 85 shares of CACI common stock through the vesting and conversion of Restricted Stock Units. This compensation-related transaction involved no open-market buying or selling. Following the transaction, he directly holds 2,322 CACI shares and 85 RSUs from a prior grant of 338 RSUs that vest in four installments.
CACI INTERNATIONAL INC /DE/ director Scott C. Morrison reported the vesting and conversion of 85 Restricted Stock Units into 85 shares of CACI Common Stock on July 13, 2026. These RSUs are part of a 338-unit grant awarded on October 16, 2025, with multiple scheduled vesting dates. Following this event, Morrison holds 584 common shares and 85 RSUs directly.
CACI International Inc. director Sloane Stanton reported a derivative exercise/conversion involving 85 Restricted Stock Units and a corresponding 85-share change in CACI common stock on July 13, 2026. Following the transactions, he holds 1,112 shares of CACI common stock directly and 85 Restricted Stock Units. A prior grant of 338 RSUs, awarded on October 16, 2025, vests in four installments: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
CACI International director Lisa S. Disbrow reported the vesting and conversion of 123 Restricted Stock Units into 123 shares of CACI common stock on July 13, 2026. This compensation-related derivative exercise increased her directly held common stock to 2,452 shares.
The RSUs relate to a grant of 492 units made on October 16, 2025, scheduled to vest in four equal installments of 123 shares on January 14, 2026, April 14, 2026, July 13, 2026 and October 11, 2026.
CACI International director Ryan D. McCarthy exercised restricted stock units on July 13, 2026, acquiring 85 shares of CACI common stock through a derivative conversion. After the transaction, he holds 2,322 common shares directly and 85 restricted stock units that are scheduled to vest in a later tranche.
CACI International director Debora A. Plunkett reported the vesting and conversion of 85 Restricted Stock Units into CACI common stock on July 13, 2026. After this derivative exercise, she directly holds 2,597 CACI common shares and retains 85 RSUs from a 338-unit grant awarded on October 16, 2025.
CACI International Inc. director Susan M. Gordon acquired 85 shares of CACI Common Stock on July 13, 2026 through the exercise and conversion of Restricted Stock Units (RSUs), not an open-market purchase. After this vesting event, she directly holds 2,726 common shares and 85 RSUs scheduled to vest on October 11, 2026.
Young David Anthony reported acquisition or exercise transactions in this Form 4 filing.
CACI International executive David Anthony Young, EVP and Chief Operating Officer, received a grant of 4,448 restricted stock units on June 22, 2026. These units represent rights linked to CACI Common Stock and vest in three equal annual installments on June 22, 2027, June 22, 2028 and June 22, 2029.
CACI International executive David Anthony Young, EVP and Chief Operating Officer, filed an initial Form 3 as a reporting person of the company. This filing establishes his status for insider reporting, but the data provided here shows no listed transactions or derivative holdings at this time.